CD8A and neoplasm: Priming of naive pathogen- or tumor-reactive CD8+ T cells (Tn CD8) occurs in secondary lymphoid organs (SLOs), where they undergo clonal expansion and differentiate into effector CD8+ T (TE) lymphocytes.